Family of patients with NAFLD and cirrhosis are at increased risk of liver fibrosis

June 19, 2017, JCI Journals

Non-alcoholic fatty liver disease (NAFLD) is a common disorder characterized by abnormal accumulation of fat in the liver. NAFLD is diagnosed in up to one in three adults and one in 10 children in the United States, and obesity is the greatest known risk factor. While NAFLD itself does not damage the liver, inflammatory responses to fat deposits can lead to liver scarring and cirrhosis. NAFLD patients that develop cirrhosis have a substantially worse prognosis, with an elevated risk of mortality due to liver disease.

Family members of individuals with NAFLD are at a higher risk for developing NAFLD themselves, but whether this is accompanied by a predisposition toward is not known. A clinical trial led by Rohit Loomba at UCSD assessed whether the immediate relatives of individuals with NAFLD and cirrhosis are at higher risk of developing advanced fibrosis.

In a a report published this week in the JCI, the researchers used an MRI-based imaging technique to quantify liver scarring (or fibrosis) in the siblings, parents, and offspring of patients with NAFLD and cirrhosis. They determined that the relatives of individuals with NAFLD and cirrhosis exhibited 12 times higher prevalence of than healthy controls, even when the researchers adjusted for age, sex, ethnicity, , and diabetes status.

These findings indicate that the immediate family members of individuals diagnosed with NAFLD and may benefit from screenings for liver fibrosis.

Explore further: Many diabetics don't know they have serious liver disease

More information: Cyrielle Caussy et al, Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI93465

Related Stories

Many diabetics don't know they have serious liver disease

September 21, 2015
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. NAFLD is a frequent finding in patients with type 2 diabetes, but the exact prevalence of NAFLD, as well as whether patients ...

NASH associated with a 50 percent higher chance of death compared with NAFLD

April 24, 2015
Results from a large population-based cohort of almost a million people in the UK found that the chances of dying from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those ...

Waist not weight—the key to non-alcoholic fatty liver disease

April 16, 2016
A new study presented today demonstrates that a build-up of fat around the waist can cause more serious complications than obesity in the development of non-alcoholic fatty liver disease (NAFLD). The study was presented at ...

Birth weight is risk factor for fatty liver disease in children

April 4, 2017
Researchers at University of California San Diego School of Medicine, with a cohort of clinical collaborators from across the United States, have demonstrated the impact of low and high birth weights in developing Non Alcoholic ...

Both low and high birth weight linked to fatty liver disease in children

April 19, 2017
A study published in the Journal of Pediatrics suggests that children born with lower or higher weight than normal may be at increased risk for developing nonalcoholic fatty liver disease (NAFLD). These children also were ...

Magnet study sees otential for MRE in measuring liver fibrosis in children

May 11, 2017
Researchers at University of California San Diego School of Medicine, with collaborators across the nation, have determined that magnetic resonance elastography (MRE) can be an accurate, non-invasive tool to identify liver ...

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.